1291 results found
Mannitol is a naturally occurring sugar alcohol from the sap of the manna ash tree that can be produced as a dry powder. In the 1990s, Dr Sandra Anderson and colleagues at Sydney's Royal Prince Alfred Hospital (RPAH) began research into how inhaled mannitol can be used to diagnose asthma. This work resulted in the development of two new pharmaceutical products, Aridol® and Bronchitol®.
Over the last 10 years NHMRC has invested more than $191 million in research on malaria1
Dr Romain Ragonnet is a Senior Research Fellow in the Epidemiological Modelling Unit at Monash University. Dr Ragonnet specialises in the mathematical modelling of tuberculosis (TB) and COVID-19, and his notable contributions include the first-ever quantification of TB mortality and self-recovery rates. Dr Ragonnet has advised various governments of lower-middle-income countries in the Asia-Pacific region to assist the local control of TB and COVID-19. He also initiated and led multiple cross-disciplinary collaborations, creating a strong network of world-leading experts that spans mathematics, medical ethics, biostatistics, economics, and clinical trials.
Road Map 3: A strategic framework for improving Aboriginal and Torres Strait Islander health through research. Report of Community Consultations. Linked to:Action Plan 2018 - 2021 Triennium to implement Road Map 3Action Plan 2021 - 2024 Triennium to implement Road Map 3Road Map 3: A strategic framework for improving Aboriginal and Torres Strait Islander health through research.
Dr Jeffrey Liddell from the University of Melbourne is a mid-career neurobiologist, with an interest in neurodegenerative diseases and understanding their underlying causes.
Statements of Expectations are issued by the responsible Minister to provide greater clarity about government policies and objectives relevant to an agency, including the policies and priorities it is expected to observe in conducting its operations. The Accountable Authority under the Public Governance, Performance and Accountability Act 2013, in the case of NHMRC, the CEO, respond to this statement with their Statement of Intent.NHMRC received a Regulatory Statement of Expectations from the Minister for Health and Ageing in December 2025 highlighting government expectations in relation to how the Office of NHMRC supports and reports on the independent regulatory functions of the Embryo Research Licensing Committee. The CEO’s response to this Statement is also provided.
Associate Professor Dina LoGiudice is a geriatrician and clinical researcher with a special interest in dementia and ageing well. For close to two decades, she has been studying the impacts of ageing and dementia in Aboriginal and Torres Strait Islander communities.
Having practised as a hospital pharmacist by day and a residential aged care pharmacist by night, Dr Lisa Pont naturally began to think about how pharmacists could work differently as part of her research.
Professor Robert Gilchrist is a part of a bench-to-bedside research success story, innovating existing infertility treatments to offer a less invasive and cheaper alternative to in-vitro fertilisation (IVF).
Immunologist Dr Jason Waithman leads the Cancer Immunotherapy Group at the Telethon Kids Institute in Western Australia.
Professor David Forbes has dedicated his career to helping people heal from trauma and, with Associate Professor Lisa Dell in his team from the University of Melbourne and their project collaborators, they are paving the way to improve the lives of Australians with PTSD.
Dr Prashant Bharadwaj's innovative research and work is paving the way for new treatments and offering hope to families affected by dementia.
The National Health and Medical Research Council (NHMRC) and the Department of Health, Disability and Ageing (responsible for the Medical Research Future Fund (MRFF)) have today launched a new requirement for applicants for funding from their grant programs.
Welcome to Tracker, the National Health and Medical Research Council’s (NHMRC) fortnightly newsletter with the latest information on major activities and funding opportunities.
Aboriginal and Torres Strait Islander health evidence-practice policy gap reports. An evidence-practice/policy gap is the difference between what is known from the best available research evidence and what is practised in reality (through delivery of medical care or drafting of policies or guidelines).